CAMLINFINE - Camlin Fine Sciences

Camlin Fine Sciences

CAMLINFINE · Chemicals > Chemicals · Chairman: Ashish Dandekar · MD: Ashish Dandekar · Listing date: Jan. 20, 2015 · Employees: 430 · Mumbai · http://www.camlinfs.com

Stock Price vs Company Growth

1.8%

4.6%

3.0%

17.7%

25.0%

39.3%

19.0%

all

2.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 104 1.8%

88.5

134

Company Overview

Sales

1,638 Cr

Growth: 1.8%

Profit after Tax

-6.45 Cr

Growth: -122.0%

Small Cap

1,737 Cr

P/S: 1.1x

Industry P/S: 2.1x

Fundamentals

Sales (Cr)	₹ 1,638
Growth	1.8%
EBITDA	7.7%
P/S	1.1x
Dividend	0.0%
P/E	-305.0x
Book Value	₹ 48.1
PEG Ratio	-168.0x
ROE	-0.8%
P/B	2.2x

Shareholding Pattern

Institutions

Icici Prudential Midcap Fund

8.62 %

Sbi Flexicap Fund

7.93 %

Infinity Direct Holding

4.82 %

Nirmal Vinod Momaya

2.82 %

Kuwait Investment Authority Fund 225

1.99 %

Promoters

Ashish Subhash Dandekar

11.02 %

Camart Industries Ltd

4.17 %

Vibha Agencies Pvt Ltd

2.04 %

Anagha Subhash Dandekar

1.19 %

Cafco Consultants Limited

1.17 %

Others

Increase Decrease No change

Company Profile Detailed

Camlin, the corporate group, was established in 1931 and is a pioneer in art and stationery material in India. Camlin diversified into Pharmaceuticals and Fine Chemicals two decades ago. The Fine Chemical Division of Camlin got de-merged into a separate company named as Camlin Fine Chemicals on 22nd December 2006. The entire management team and employees of Camlin Fine Chemicals Division are now a part of the independent legal entity formed under the Indian Companies Act 1956.

Belongs to (6 Indices) view more

Investors (91)

copthall...

visa.cap...

gajanan....

Followers (6)

sudheer....

ratnesh2

indrajee...